Home
About
Overview
Sharing Data
ORCID
Help
History (8)
LKB1 Deficiency Renders NSCLC Cells Sensitive to ERK Inhibitors.
Nickson, Pamela
Hostile attributional bias, negative emotional responding, and aggression in adults: moderating effects of gender and impulsivity.
Early-Stage Lung Cancer: Using Circulating Tumor DNA to Get Personal.
Management of infusion-related reactions (IRRs) in patients receiving amivantamab in the CHRYSALIS study.
See All 8 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Management of infusion-related reactions (IRRs) in patients receiving amivantamab in the CHRYSALIS study.
Management of infusion-related reactions (IRRs) in patients receiving amivantamab in the CHRYSALIS study. Lung Cancer. 2023 04; 178:166-171.
View in:
PubMed
subject areas
Animals
Antibodies, Bispecific
Carcinoma, Non-Small-Cell Lung
Drug-Related Side Effects and Adverse Reactions
ErbB Receptors
Humans
Immune System Diseases
Lung Neoplasms
Pupa
authors with profiles
Ravi Salgia